• Hilal Maradit Kremers, Laura W Lewallen, Tad M Mabry, Daniel J Berry, Elie F Berbari, and Douglas R Osmon.
• Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
• J Arthroplasty. 2015 Mar 1;30(3):439-43.

AbstractDiabetes mellitus is an established risk factor for infections but evidence is conflicting to what extent perioperative hyperglycemia, glycemic control and treatment around the time of surgery modify the risk of prosthetic joint infections (PJIs). In a cohort of 20,171 total hip and knee arthroplasty procedures, we observed a significantly higher risk of PJIs among patients with a diagnosis of diabetes mellitus (hazard ratio [HR] 1.55, 95% CI 1.11, 2.16), patients using diabetes medications (HR 1.56, 95% CI 1.08, 2.25) and patients with perioperative hyperglycemia (HR 1.59, 95% CI 1.07, 2.35), but the effects were attenuated after adjusting for body mass index, type of surgery, ASA score and operative time. Although data were limited, there was no association between hemoglobin A1c values and PJIs.Copyright © 2014 Elsevier Inc. All rights reserved.

33 keywords...

hide…